These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22487172)

  • 1. RNA plasticity and selectivity applicable to therapeutics and novel biosensor development.
    Nakamura Y; Ishiguro A; Miyakawa S
    Genes Cells; 2012 May; 17(5):344-64. PubMed ID: 22487172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers as therapeutic middle molecules.
    Nakamura Y
    Biochimie; 2018 Feb; 145():22-33. PubMed ID: 29050945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application.
    Adachi T; Nakamura Y
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamers as molecular recognition elements in chromatographic separations.
    Hutanu D; Remcho VT
    Adv Chromatogr; 2007; 45():173-96. PubMed ID: 17626559
    [No Abstract]   [Full Text] [Related]  

  • 5. Conformational plasticity of RNA for target recognition as revealed by the 2.15 A crystal structure of a human IgG-aptamer complex.
    Nomura Y; Sugiyama S; Sakamoto T; Miyakawa S; Adachi H; Takano K; Murakami S; Inoue T; Mori Y; Nakamura Y; Matsumura H
    Nucleic Acids Res; 2010 Nov; 38(21):7822-9. PubMed ID: 20675355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamers and aptamer targeted delivery.
    Yan AC; Levy M
    RNA Biol; 2009; 6(3):316-20. PubMed ID: 19458497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers as therapeutics.
    Keefe AD; Pai S; Ellington A
    Nat Rev Drug Discov; 2010 Jul; 9(7):537-50. PubMed ID: 20592747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acid aptamers against biotoxins: a new paradigm toward the treatment and diagnostic approach.
    Lauridsen LH; Veedu RN
    Nucleic Acid Ther; 2012 Dec; 22(6):371-9. PubMed ID: 23113767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA aptamers to translational components.
    Nakamura Y; Endo K; Adachi H; Ishiguro A
    Prog Mol Biol Transl Sci; 2009; 90():369-95. PubMed ID: 20374747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplexed aptamers: history, design, theory, and application to biosensing.
    Munzar JD; Ng A; Juncker D
    Chem Soc Rev; 2019 Mar; 48(5):1390-1419. PubMed ID: 30707214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen.
    Lee S; Kim YS; Jo M; Jin M; Lee DK; Kim S
    Biochem Biophys Res Commun; 2007 Jun; 358(1):47-52. PubMed ID: 17475212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational design of RNA libraries for in vitro selection of aptamers.
    Chushak YG; Martin JA; Chávez JL; Kelley-Loughnane N; Stone MO
    Methods Mol Biol; 2014; 1111():1-15. PubMed ID: 24549608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-quadruplex-based aptamers against protein targets in therapy and diagnostics.
    Platella C; Riccardi C; Montesarchio D; Roviello GN; Musumeci D
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1429-1447. PubMed ID: 27865995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple fluorescent biosensor for theophylline based on its RNA aptamer.
    Rankin CJ; Fuller EN; Hamor KH; Gabarra SA; Shields TP
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(12):1407-24. PubMed ID: 17067962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
    Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
    RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of RNA aptamers against SRP19 protein having sequences different from SRP RNA.
    Haraguchi Y; Kuwasako K; Muto Y; Bessho Y; Nishimoto M; Yokoyama S; Kanai A; Kawai G; Sakamoto T
    Nucleic Acids Symp Ser (Oxf); 2009; (53):265-6. PubMed ID: 19749362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of DNA aptamers that inhibit enzymatic activity of PQQGDH and its application.
    Ikebukuro K; Takase M; Sode K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):403-4. PubMed ID: 18029757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Customised nucleic acid libraries for enhanced aptamer selection and performance.
    Pfeiffer F; Rosenthal M; Siegl J; Ewers J; Mayer G
    Curr Opin Biotechnol; 2017 Dec; 48():111-118. PubMed ID: 28437710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Aptamer Discovery and Applications.
    Zhang Y; Lai BS; Juhas M
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.